Warby Parker Inc. WRBY

Healthcare SIC 3851 - Ophthalmic Goods NAICS Manufacturing › Miscellaneous Manufacturing › Medical Equipment and Supplies Manufacturing › Ophthalmic Goods Manufacturing derived NYSE

Warby Parker is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. We stand for fun, creativity, and doing good in the world. Every day, our team of over 4,000 employees is focused on our mission to inspire and impact the world with vision, purpose, and style (without charging a premium for it). Our ultimate objective is to provide vision for all.

As a pioneer of the direct-to-consumer model, we design our glasses in-house at our New York City headquarters and sell directly to customers, enabling us to make high-quality, designer eyewear more accessible, with simple, unified pricing starting at $95 including prescription lenses. Since our launch, we've expanded beyond glasses to offer comprehensive eye care, including eye exams, contacts, lens enhancements and tech-enabled experiences like Virtual Try-On and Virtual Vision Test, with an aim to make Warby Parker a convenient, one-stop shop for all eye care needs. We operate an integrated, omnichannel platform across digital commerce and 323 retail stores as of December 31, 2025, all designed to make shopping both convenient and fun.

Last close 25.91 2026-10-23
Market cap $3.21B estimated share count
52-week range 14.96 - 31.00

Valuation FY2025 figures against the last close

P/S3.7x
P/E2,591.0x
P/FCF73.4x
EV/EBITDA71.4x
Dividend yield—
Diluted EPS0.01

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue $871.9M$771.3M$669.8M$598.1M$540.8M$393.7M$370.5M—
Cost of revenue $401.3M$344.5M$304.5M$257.1M$223.0M$161.8M$147.4M—
Gross profit $470.6M$426.8M$365.2M$341.1M$317.7M$231.9M$223.1M—
SG&A $475.9M$456.9M$437.2M$452.3M$461.4M$287.6M$224.8M—
Operating income -$5.3M-$30.1M-$72.0M-$111.2M-$143.7M-$55.6M-$1.7M—
Pre-tax income $3.0M-$19.5M-$62.8M-$109.9M-$144.0M-$55.7M$276.0K—
Income tax $1.4M$875.0K$433.0K$497.0K$263.0K$190.0K$276.0K—
Net income $1.6M-$20.4M-$63.2M-$110.4M-$144.3M-$55.9M$0—
EPS, basic 0.01-0.17-0.54-0.96-2.21-1.05-1.10—
EPS, diluted 0.01-0.17-0.54-0.96-2.21-1.05-1.10—
Shares, diluted (wtd. avg.) 125.1M120.4M117.4M114.9M71.2M53.0M52.4M—

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents $286.4M$254.2M$216.9M$208.6M$256.4M$314.1M$55.4M$149.8M
Receivables $3.3M$1.9M$1.8M$1.4M$992.0K$601.0K——
Inventory $44.5M$52.3M$62.2M$68.8M$57.1M$38.5M——
Total current assets $352.4M$326.0M$298.6M$294.6M$328.0M$359.9M——
Property, plant and equipment $187.4M$170.5M$152.3M$138.6M$112.2M$84.5M——
Total assets $720.9M$676.5M$580.3M$568.7M$440.6M$444.8M——
Accounts payable $32.0M$23.5M$22.5M$20.8M$30.9M$40.8M——
Total current liabilities $150.1M$130.4M$127.1M$129.6M$118.1M$105.3M——
Total liabilities $353.2M$336.4M$278.5M$282.1M$154.6M$136.3M——
Retained earnings -$685.6M-$687.2M-$666.8M-$603.6M-$493.2M-$325.4M——
Total equity $367.7M$340.1M$301.8M$286.6M$286.0M-$198.1M-$189.5M-$133.6M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating cash flow $110.8M$98.7M$61.0M$10.4M-$32.0M$32.8M$21.4M—
Depreciation and amortisation $50.3M$45.9M$38.6M$31.9M$21.6M$17.8M$14.5M—
Stock-based compensation $34.5M$47.3M$70.5M$98.0M$107.1M$44.9M$8.5M—
Capital expenditure $67.0M$64.0M$53.7M$60.2M$48.5M$20.1M$32.6M—
Investing cash flow -$67.0M-$66.0M-$54.7M-$60.2M-$48.5M-$20.1M-$32.6M—
Financing cash flow -$12.0M$5.0M$2.9M$3.3M$23.0M$245.9M-$83.4M—
Buybacks ——$0$0$8.1M$0$79.5M—

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001104659-26-050432.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -500M 0 500M 1B Revenue, FY2019: 370.5M Gross profit, FY2019: 223.1M Net income, FY2019: 0 Revenue, FY2020: 393.7M Gross profit, FY2020: 231.9M Net income, FY2020: -55.9M Revenue, FY2021: 540.8M Gross profit, FY2021: 317.7M Net income, FY2021: -144.3M Revenue, FY2022: 598.1M Gross profit, FY2022: 341.1M Net income, FY2022: -110.4M Revenue, FY2023: 669.8M Gross profit, FY2023: 365.2M Net income, FY2023: -63.2M Revenue, FY2024: 771.3M Gross profit, FY2024: 426.8M Net income, FY2024: -20.4M Revenue, FY2025: 871.9M Gross profit, FY2025: 470.6M Net income, FY2025: 1.6M FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue — $370.5M $393.7M $540.8M $598.1M $669.8M $771.3M $871.9M
Gross profit — $223.1M $231.9M $317.7M $341.1M $365.2M $426.8M $470.6M
Net income — $0 -$55.9M -$144.3M -$110.4M -$63.2M -$20.4M $1.6M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Regulation FD disclosure Item 7.01
  • Results announced Item 2.02
  • Results announced Item 2.02
  • Officer or director change Item 5.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 3851

TickerCompanyMarket capP/ERevenue growth
COO COOPER COMPANIES, INC. $11.94B 32.7x 5.1%
BLCO Bausch & Lomb Corp $6.24B — 6.5%
EYE National Vision Holdings, Inc. $1.48B 50.5x 9.0%
STAA STAAR SURGICAL CO $1.13B — -23.7%
RXST RxSight, Inc. $208.8M — -3.9%
LUCY Innovative Eyewear Inc $7.5M — 62.6%
ALC ALCON INC — — 4.9%